Literature DB >> 21742314

Ozonolysis of the double bond of the unsaturated uronate residue in low-molecular-weight heparin and K5 heparosan.

Sayaka Masuko1, Kyohei Higashi, Zhenyu Wang, Ujjwal Bhaskar, Anne Marie Hickey, Fuming Zhang, Toshihiko Toida, Jonathan S Dordick, Robert J Linhardt.   

Abstract

Ozone is known to add across and cleave carbon-carbon double bonds. Ozonolysis is widely used for the preparation of pharmaceuticals, for bleaching substances and for killing microorganisms in air and water sources. Some polysaccharides and oligosaccharides, such as those prepared using chemical or enzymatic β-elimination, contain a site of unsaturation. We examined ozonolysis of low-molecular-weight heparins (LMWHs), enoxaparin and logiparin, and heparosan oligo- and polysaccharides for the removal of the nonreducing terminal unsaturated uronate residue. 1D (1)H NMR showed that these ozone-treated polysaccharides retained the same structure as the starting polysaccharide, except that the C4-C5 double bond in the nonreducing end unsaturated uronate had been removed. The anticoagulant activity of the resulting product from enoxaparin and logiparin was comparable to that of the starting material. These results demonstrate that ozonolysis is an important tool for the removal of unsaturated uronate residues from LMWHs and heparosan without modification of the core polysaccharide structure or diminution of anticoagulant activity. This reaction also has potential applications in the chemoenzymatic synthesis of bioengineered heparin from Escherichia coli-derived K5 heparosan.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21742314      PMCID: PMC3229283          DOI: 10.1016/j.carres.2011.06.004

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  18 in total

1.  2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity.

Authors:  Robert J Linhardt
Journal:  J Med Chem       Date:  2003-06-19       Impact factor: 7.446

Review 2.  Production and chemical processing of low molecular weight heparins.

Authors:  R J Linhardt; N S Gunay
Journal:  Semin Thromb Hemost       Date:  1999       Impact factor: 4.180

3.  Formation of anhydrosugars in the chemical depolymerization of heparin.

Authors:  J E Shively; H E Conrad
Journal:  Biochemistry       Date:  1976-09-07       Impact factor: 3.162

4.  Oligosaccharide mapping of low molecular weight heparins: structure and activity differences.

Authors:  R J Linhardt; D Loganathan; A al-Hakim; H M Wang; J M Walenga; D Hoppensteadt; J Fareed
Journal:  J Med Chem       Date:  1990-06       Impact factor: 7.446

5.  Complications of heparin therapy.

Authors:  A S Gervin
Journal:  Surg Gynecol Obstet       Date:  1975-05

6.  Differential anticoagulant activity of heparin fragments prepared using microbial heparinase.

Authors:  R J Linhardt; A Grant; C L Cooney; R Langer
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

Review 7.  Pharmacodynamics, clinical indications, and adverse effects of heparin.

Authors:  M D Freedman
Journal:  J Clin Pharmacol       Date:  1992-07       Impact factor: 3.126

8.  Reaction of unsaturated uronic acid residues with mercuric salts. Cleavage of the hyaluronic acid disaccharide 2-acetamido-2-deoxy-3-O-(beta-D-gluco-4-enepyranosyluronic acid)-D-glucose.

Authors:  U Ludwigs; A Elgavish; J D Esko; E Meezan; L Rodén
Journal:  Biochem J       Date:  1987-08-01       Impact factor: 3.857

9.  The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin.

Authors:  W F Vann; M A Schmidt; B Jann; K Jann
Journal:  Eur J Biochem       Date:  1981-05-15

Review 10.  Lessons learned from the contamination of heparin.

Authors:  Haiying Liu; Zhenqing Zhang; Robert J Linhardt
Journal:  Nat Prod Rep       Date:  2009-01-19       Impact factor: 13.423

View more
  4 in total

1.  Photochemical Preparation of a Novel Low Molecular Weight Heparin.

Authors:  Kyohei Higashi; Saori Hosoyama; Asami Ohno; Sayaka Masuko; Bo Yang; Eric Sterner; Zhenyu Wang; Robert J Linhardt; Toshihiko Toida
Journal:  Carbohydr Polym       Date:  2012-02-01       Impact factor: 9.381

2.  Synthesis of heparosan oligosaccharides by Pasteurella multocida PmHS2 single-action transferases.

Authors:  Anaïs A E Chavaroche; Lambertus A M van den Broek; Carmen Boeriu; Gerrit Eggink
Journal:  Appl Microbiol Biotechnol       Date:  2011-12-24       Impact factor: 4.813

Review 3.  Engineered heparins as new anticoagulant drugs.

Authors:  Deepika Vaidyanathan; Asher Williams; Jonathan S Dordick; Mattheos A G Koffas; Robert J Linhardt
Journal:  Bioeng Transl Med       Date:  2016-11-21

4.  Discovery of exolytic heparinases and their catalytic mechanism and potential application.

Authors:  Qingdong Zhang; Hai-Yan Cao; Lin Wei; Danrong Lu; Min Du; Min Yuan; Deling Shi; Xiangxue Chen; Peng Wang; Xiu-Lan Chen; Lianli Chi; Yu-Zhong Zhang; Fuchuan Li
Journal:  Nat Commun       Date:  2021-02-24       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.